Allegiant Travel enters the back half of June with a rare combination pulling in opposite directions: the stock has climbed 28% in a month, Goldman Sachs just slapped a fresh Buy rating on it this morning, and yet short interest has simultaneously jumped 54% in a single week — the most striking short-interest rebuild in the airline space right now.
The positioning story is the most interesting tension on the tape. Short interest has surged to 9.2% of free float, up from roughly 6% a week ago — a sharp swing that looks like fresh conviction shorts rather than a technical artefact. The jump came as the stock itself was ripping higher, meaning bears are actively leaning into a rally, not chasing a move down. That said, the lending market gives them no trouble doing so: availability is extremely loose at 4,726% of short interest, borrowing costs are a negligible 0.55%, and the 52-week utilization peak was just 26%. There is no squeeze pressure here — the short side can add freely, and the cost of being wrong is cheap. Options sentiment is equally calm, with the put/call ratio at 0.59, essentially flat with its 20-day average and the z-score just -0.1. Neither bulls nor bears are paying up for protection.
The Street headline this week belongs to Goldman. Analyst Catherine O'Brien reinstated coverage this morning with a Buy and a $125 price target — 30% above last night's close of $95.92 and the most aggressive target on the board. That stands apart from the broader analyst consensus, which is more cautious. B of A Securities raised its target to $100 in early June but held its Neutral rating. UBS and Citigroup are also both Neutral, with targets in the $93–$98 range from actions taken in March. The overall consensus is technically a Buy, but only five analysts hold that rating, and Goldman's reinstatement is doing much of the heavy lifting. The valuation framework offers some support for the bulls: the EV/EBITDA multiple has compressed by more than one full turn over the past 30 days — now at 4.3x — while the trailing P/E of 13.5x has expanded with the price move. The 30-day forward EPS momentum ranks in the 93rd percentile, meaning earnings estimate revisions have been running hard to the upside.
The institutional picture adds another layer. BlackRock added 519,000 shares in its most recent filing, lifting its stake to 7.8% of shares outstanding — the largest institutional position in the name. American Century and Vanguard also built meaningful new positions recently. Founder and Chairman/CEO Maurice Gallagher holds 7.7% but sold just over $14 million in stock in February at prices around $114–$116 — well above where the stock trades today. The COO Jude Bricker followed in May, selling 40,437 shares at $75.21 for just over $3 million. That insider selling at higher levels sits awkwardly against the institutional buying at lower levels, though both could reflect separate motivations: executives taking planned distributions, institutions seeing value after the drawdown.
The earnings calendar is worth marking. Allegiant's most recent Q1 print on April 30 generated a muted one-day response of under 1%, but the five-day follow-through was a solid 10% gain. The prior Q4 print in February produced a 7% single-day move and a 18% five-day rally. Q2 results are slated for August 5 — the next hard date that will test whether the recovery narrative Goldman is buying into holds up against actual numbers. Between now and then, the key question is whether the 54% weekly short-interest rebuild represents informed conviction or momentum-chasing into a thin float — and whether those fresh shorts face an increasingly crowded exit if the Goldman call gains traction across the Street.
See the live data behind this article on ORTEX.
Open ALGT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
